Contract award · 12 Feb 2024

Cancer Vaccines Launch Pad

NHS England awarded “Cancer Vaccines Launch Pad” to University of Southampton for £1.4m on 12 Feb 2024.

Health & social careYorkshire and the Humber

BuyerNHS England
Value £1.4m

Open competition

Open procedure: the contract was advertised and any supplier could submit a bid.

Key facts

Buyer
NHS England · Body governed by public law
Value
£1,397,952
Procedure
Open procedure
Sector
Health & social care · Health services (CPV 85100000)
Timeline
  1. Contract date12 Feb 2024
  2. Published29 Feb 2024Published 17 days after the contract date

Description

The CVLP is a feasibility study, facilitating access to personalised treatment cancer trials, for example cancer vaccines. Patients will be identified across a network of up to 140 NHS cancer care providers. Patients in the CVLP will be asked to consent for analysis of their tumour material, peripheral blood (if trial requires), and clinical data to establish whether they might be suitable for current or future cancer vaccine trials. The detail of any available trials will be shared with the participant and their treating clinical team, to see if they would consider taking part in the trial(s) for which they are eligible.

About the supplier

More from NHS England

All contracts

More won by University of Southampton

All contracts

Recent health & social care contracts

Sector overview